The McGraw Group

Synthego, based in Redwood City, CA, specializes in advancing CRISPR-based therapeutics with a comprehensive range of innovative solutions, including Research-Use Only (RUO) and Good Manufacturing Practice (GMP) compliant products. The company's expertise spans from early-stage research to clinical trials, streamlining the development of cell and gene therapies with a focus on regulatory support and high-quality CRISPR technologies. Committed to accelerating life science research and improving human health, Synthego offers a variety of CRISPR solutions, including synthesized gRNA and nucleases, aimed at enhancing the efficiency and affordability of therapeutic development. Their team also provides essential RNA enzymes and regulatory guidance to navigate the complexities of bringing therapies to market. Generated from the website